The COVID-19 recession of 2020 may potentially result in permanent benefit cuts for about 4 million people. Q & 038; March 2021 Can You Tell Me My Full Retirement Age? .Fortunately, H.R. 3 is not the only legislation in either house of Congress that could lower drug prices and accomplish the other things necessary to fix Medicare and Social Security. .Source: "The 2018 Long-Term Budget Outlook," The Congressional Budget Office, June 2018. .Both retirees and the disabled spend a very significant portion of their incomes on healthcare costs. For many, health insurance premiums are the most significant expense that they incur every month. That includes what the government automatically deducts for Medicare Part B, and what individuals shell out for a Medicare Advantage plan or Medigap policy, and Part D drug plan. According to a policy brief from the Kaiser Family Foundation, premiums account for the largest share of Medicare beneficiaries' out-of-pocket health spending. Four-in-ten Medicare beneficiaries spend more than 10 percent of their income on premiums alone. To get a better idea of what the government does track, here's a list from the Bureau of Labor Statistics (BLS). The BLS has classified all expenditure items into more than 200 categories, arranged into eight major groups. Major groups and examples of categories in each include: .During the most recent years for which data are available (2000-2004), the total number of mismatched wage reports jumped from 217 million at the end of 1999 to 264 million by 2004, an average of more than 9.3 million per year—82% higher than during the 1990's and more than double the rate of the 1980's. .This week, The Senior Citizens League was pleased to see support grow for three bipartisan bills that would improve the Medicare program and reduce prescription drug prices. .Mary: Who tends to use anchors to influence our decisions, and when should we be wary? .Manufacturers have traditionally claimed that only the lure of windfall profits would encourage them to take the necessary risks, since drug development is expensive and there's no way of knowing whether they're putting their money on a horse that will finish first, or scratch. .The future of the AHCA remains uncertain in the House, and in the Senate, lawmakers have been even more cautious about its prospects. On Wednesday, Senate Majority Whip John Cornyn (TX) said: "Once [House lawmakers] pass the bill, my assumption is, the Senate's going to take a look at it but not necessarily be rubber-stamping what they're proposing. I would anticipate that we'll do what we used to do all the time which is, the House will pass a bill, we'll pass a bill, and then we'll reconcile those in a conference committee."